November 9, 2016Ionis Pharmaceuticals Reports Financial Results and Highlights for Third Quarter 2016
November 7, 2016Biogen and Ionis Pharmaceuticals Announce SPINRAZA (nusinersen) Meets Primary Endpoint at Interim Analysis of Phase 3 CHERISH Study in Later-Onset Spinal Muscular Atrophy
Ionis Pharmaceuticals Presents New Preclinical Data at the North American Cystic Fibrosis Conference
CHMP of the EMA has Granted Nusinersen Accelerated Assessment
Ionis Receives Drug Discovery Award to Support Cystic Fibrosis Research
Newly Published Data Demonstrate a Novel Pro-inflammatory Mechanism for Lp(a) in Humans
We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »
No upcoming events at this time...